The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Mesenchymal Stromal Cells Promote Tumor Growth through the Enhancement of Neovascularization
Open accessAbstract
Mesenchymal stromal cells (MSCs), also called mesenchymal stem cells, migrate and function as stromal cells in tumor tissues. The effects of MSCs on tumor growth are controversial. In this study, we showed that MSCs increase proliferation of tumor cells in vitro and promote tumor growth in vivo. We also further analyzed the mechanisms that underlie these effects. For use in in vitro and in vivo experiments, we established a bone marrow-derived mesenchymal stromal cell line from cells isolated in C57BL/6 mice. Effects of murine MSCs on tumor cell proliferation in vitro were analyzed in a coculture model with B16-LacZ cells. Both coculture with MSCs and treatment with MSC-conditioned media led to enhanced growth of B16-LacZ cells, although the magnitude of growth stimulation in cocultured cells was greater than that of cells treated with conditioned media. Co-injection of B16-LacZ cells and MSCs into syngeneic mice led to increased tumor size compared with injection of B16-LacZ cells alone. Identical experiments using Lewis lung carcinoma (LLC) cells instead of B16-LacZ cells yielded similar results. Consistent with a role for neovascularization in MSC-mediated tumor growth, tumor vessel area was greater in tumors resulting from co-injection of B16-LacZ cells or LLCs with MSCs than in tumors induced by injection of cancer cells alone. Co-injected MSCs directly supported the tumor vasculature by localizing close to vascular walls and by expressing an endothelial marker. Furthermore, secretion of leukemia inhibitory factor, macrophage colony-stimulating factor, macrophage inflammatory protein-2 and vascular endothelial growth factor was increased in cocultures of MSCs and B16-LacZ cells compared with B16-LacZ cells alone. Together, these results indicate that MSCs promote tumor growth both in vitro and in vivo and suggest that tumor promotion in vivo may be attributable in part to enhanced angiogenesis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Moreover, newer studies have depicted that injection of MSC subcutaneously develops tumor growth and neovascularization in syngeneic mouse models by promoting tumor vasculature and secreting proangiogenic factors [110].”
From Mesenchymal stromal cells in bone marrow niche of patients with multiple myeloma: a double-edged sword (2025) · cites this paper as [110]
Citations
Cites
Multilineage potential of adult human mesenchymal stem cells
Pittenger, M. F., Mackay, A. M., Beck, S. C., Jaiswal, R. K., Douglas, R., Mosca, J. D., Moorman, M. A., Simonetti, D. W., Craig, S., & Marshak, D. R. (1999) · Science · doi:10.1126/science.284.5411.143 · Cited by 21,052
Marrow Stromal Cells as Stem Cells for Nonhematopoietic Tissues
Prockop, D. J. (1997) · Science · doi:10.1126/science.276.5309.71 · Cited by 4,629
Tumors: Wounds That Do Not Heal
Flier, J. S., Underhill, L. H., & Dvorak, H. F. (1986) · New England Journal of Medicine · doi:10.1056/nejm198612253152606 · Cited by 4,391 · cited 1×
“INTRODUCTION Growth of solid tumors requires formation of the tumor stroma, which supplies oxygen and nutrients to tumor cells (1).”
Mesenchymal stem cells within tumour stroma promote breast cancer metastasis
Karnoub, A. E., Dash, A. B., Vo, A. P., Sullivan, A., Brooks, M. W., Bell, G. W., Richardson, A. L., Polyak, K., Tubo, R., & Weinberg, R. A. (2007) · Nature · doi:10.1038/nature06188 · Cited by 3,206
Bissell, M. J., & Radisky, D. (2001) · Nature Reviews Cancer · doi:10.1038/35094059 · Cited by 2,180
Ortiz, L. A., Gambelli, F., McBride, C., Gaupp, D., Baddoo, M., Kaminski, N., & Phinney, D. G. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1432929100 · Cited by 1,462
Mesenchymal Stem Cell Homing: The Devil Is in the Details
Karp, J. M., & Leng Teo, G. S. (2009) · Cell Stem Cell · doi:10.1016/j.stem.2009.02.001 · Cited by 1,445
Campagnoli, C., Roberts, I. A. G., Kumar, S., Bennett, P. R., Bellantuono, I., & Fisk, N. M. (2001) · Blood · doi:10.1182/blood.v98.8.2396 · Cited by 1,347
Immunosuppressive effect of mesenchymal stem cells favors tumor growth in allogeneic animals
Djouad, F., Plence, P., Bony, C., Tropel, P., Apparailly, F., Sany, J., Noël, D., & Jorgensen, C. (2003) · Blood · doi:10.1182/blood-2003-04-1193 · Cited by 1,166
Cancer-Associated Stromal Fibroblasts Promote Pancreatic Tumor Progression
Hwang, R. F., Moore, T. T., Arumugam, T., Ramachandran, V., Amos, K. D., Rivera, A. M., Ji, B., Evans, D. B., & Logsdon, C. D. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5714 · Cited by 1,117
Carcinoma-produced factors activate myeloid cells through TLR2 to stimulate metastasis
Kim, S., Takahashi, H., Lin, W.-W., Descargues, P., Grivennikov, S., Kim, Y., Luo, J.-L., & Karin, M. (2009) · Nature · doi:10.1038/nature07623 · Cited by 1,100
Carcinoma-associated fibroblast-like differentiation of human mesenchymal stem cells
Mishra, P. J., Mishra, P. J., Humeniuk, R., Medina, D. J., Alexe, G., Mesirov, J. P., Ganesan, S., Glod, J. W., & Banerjee, D. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0943 · Cited by 912
Studeny, M., Marini, F. C., Dembinski, J. L., Zompetta, C., Cabreira-Hansen, M. D. G., Bekele, B. N., Champlin, R. E., & Andreeff, M. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh299 · Cited by 841
Spaeth, E. L., Dembinski, J. L., Sasser, A. K., Watson, K., Klopp, A., Hall, B., Andreeff, M., & Marini, F. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004992 · Cited by 807
Human mesenchymal stem cells exert potent antitumorigenic effects in a model of Kaposi's sarcoma
Khakoo, A. Y., Pati, S., Anderson, S. A., Reid, W., Elshal, M. F., Rovira, I. I., Nguyen, A. T., Malide, D., Combs, C. A., Hall, G., et al. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20051921 · Cited by 747
Kidd, S. M., Spaeth, E. L., Dembinski, J. L., Dietrich, M. F., Watson, K., Klopp, A. H., Battula, V. L., Weil, M., Andreeff, M., & Marini, F. C. (2009) · Stem Cells · doi:10.1002/stem.187 · Cited by 680
Lian, Q., Zhang, Y., Zhang, J., Zhang, H. K., Wu, X., Zhang, Y., Lam, F. F. Y., Kang, S., Xia, J., Lai, W., et al. (2010) · Circulation · doi:10.1161/circulationaha.109.898312 · Cited by 623
Bone marrow contribution to tumor-associated myofibroblasts and fibroblasts
Direkze, N. C., Hodivala-Dilke, K., Jeffery, R., Hunt, T., Poulsom, R., Oukrif, D., Alison, M. R., & Wright, N. A. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1708 · Cited by 530
VEGF expression by mesenchymal stem cells contributes to angiogenesis in pancreatic carcinoma
Beckermann, B. M., Kallifatidis, G., Groth, A., Frommhold, D., Apel, A., Mattern, J., Salnikov, A. V., Moldenhauer, G., Wagner, W., Diehlmann, A., et al. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604508 · Cited by 406
Ramasamy, R., Lam, E. W.-F., Soeiro, I., Tisato, V, Bonnet, D., & Dazzi, F. (2007) · Leukemia · doi:10.1038/sj.leu.2404489 · Cited by 404
Migratory neighbors and distant invaders: tumor-associated niche cellsPreprint
Wels, J., Kaplan, R. N., Rafii, S., & Lyden, D. C. (2008) · Genes & Development · doi:10.1101/gad.1636908 · Cited by 392
Concentration-dependent inhibition of angiogenesis by mesenchymal stem cells
Otsu, K., Das, S., Houser, S., Quadri, S. K., Bhattacharya, S., & Bhattacharya, J. (2008) · Blood · doi:10.1182/blood-2008-09-176198 · Cited by 348
Klopp, A. H., Spaeth, E. L., Dembinski, J. L., Woodward, W. A., Munshi, A., Meyn, R. E., Cox, J. D., Andreeff, M., & Marini, F. C. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1406 · Cited by 304
Hypoxia Promotes Murine Bone‐Marrow‐Derived Stromal Cell Migration and Tube Formation
Annabi, B., Lee, Y., Turcotte, S., Naud, E., Desrosiers, R. R., Champagne, M. A., Eliopoulos, N., Galipeau, J., & Béliveau, R. (2003) · Stem Cells · doi:10.1634/stemcells.21-3-337 · Cited by 302
Coffelt, S. B., Marini, F. C., Watson, K., Zwezdaryk, K. J., Dembinski, J. L., LaMarca, H. L., Tomchuck, S. L., zu Bentrup, K. H., Danka, E. S., Henkle, S. L., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0900244106 · Cited by 302
Romieu, R., François, M., Boivin, M., Bouchentouf, M., Spaner, D., & Galipeau, J. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0803864 · Cited by 299
Hypoxia affects mesenchymal stromal cell osteogenic differentiation and angiogenic factor expression
Potier, E., Ferreira, E., Andriamanalijaona, R., Pujol, J. ‐., Oudina, K., Logeart‐Avramoglou, D., & Petite, H. (2007) · Bone · doi:10.1016/j.bone.2006.11.024 · Cited by 295
Paulsson, J., Sjöblom, T., Micke, P., Pontén, F., Landberg, G., Heldin, C., Bergh, J. C. S., Brennan, D. J., Jirström, K., & Östman, A. (2009) · American Journal Of Pathology · doi:10.2353/ajpath.2009.081030 · Cited by 269
Gunn, W., Conley, A., Deininger, L., Olson, S. D., Prockop, D. J., & Gregory, C. A. (2005) · Stem Cells · doi:10.1634/stemcells.2005-0220 · Cited by 260
Bexell, D., Gunnarsson, S., Tormin, A., Darabi, A., Gisselsson, D., Roybon, L., Scheding, S., & Bengzon, J. (2008) · Molecular Therapy · doi:10.1038/mt.2008.229 · Cited by 255
Studebaker, A. W., Storci, G., Werbeck, J. L., Sansone, P., Sasser, A. K., Tavolari, S., Huang, T. H. ‐., Chan, M. W. Y., Marini, F. C., Rosol, T. J., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0400 · Cited by 231
Grugan, K. D., Miller, C. G., Yao, Y., Michaylira, C. Z., Ohashi, S., Klein–Szanto, A. J., Diehl, J. A., Herlyn, M., Han, M., Nakagawa, H., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0914295107 · Cited by 186
Utispan, K., Thuwajit, P., Abiko, Y., Charngkaew, K., Paupairoj, A., Chau‐in, S., & Thuwajit, C. (2010) · Molecular Cancer · doi:10.1186/1476-4598-9-13 · Cited by 149
Multipotent marrow stromal cell line is able to induce hematopoiesis in vivo
Umezawa, A., Maruyama, T., Segawa, K., Shadduck, R. K., Waheed, A., & Hata, J.-I. (1992) · Journal of Cellular Physiology · doi:10.1002/jcp.1041510125 · Cited by 127
Self-citationSasser, A. K., Mundy-Bosse, B. L., Smith, K. M., Studebaker, A. W., Axel, A. E., Haidet, A. M., Fernández, S., & Hall, B. M. (2007) · Cancer Letters · doi:10.1016/j.canlet.2007.03.012 · Cited by 121
Worthley, D. L., Ruszkiewicz, A. R., Davies, R., Moore, S., Nivison‐Smith, I., To, L. B., Browett, P., Western, R., Durrant, S., So, J. B. Y., et al. (2009) · Stem Cells · doi:10.1002/stem.63 · Cited by 104
Udagawa, T., Puder, M., Wood, M. L., Schaefer, B. C., & D’Amato, R. J. (2006) · The FASEB Journal · doi:10.1096/fj.04-3669com · Cited by 69
Watanabe, Y., Mazda, O., Aiba, Y., Iwaï, K., Gyotoku, J.-I., Ideyama, S., Miyazaki, J., & Katsura, Y. (1992) · Cellular Immunology · doi:10.1016/0008-8749(92)90299-5 · Cited by 33
Cited by
Sorted by citations
Progression and metastasis of lung cancer
Popper, H. (2016) · Cancer and Metastasis Reviews · doi:10.1007/s10555-016-9618-0 · Cited by 551
The Pros and Cons of Mesenchymal Stem Cell-Based Therapies
Musiał-Wysocka, A., Kot, M., & Majka, M. (2019) · Cell Transplantation · doi:10.1177/0963689719837897 · Cited by 553
Mesenchymal stem cells: key players in cancer progression
Ridge, S. M., Sullivan, F. J., & Glynn, S. A. (2017) · Molecular Cancer · doi:10.1186/s12943-017-0597-8 · Cited by 526
Biodistribution, migration and homing of systemically applied mesenchymal stem/stromal cells
Leibacher, J., & Henschler, R. (2016) · Stem Cell Research & Therapy · doi:10.1186/s13287-015-0271-2 · Cited by 368
Bronckaers, A., Hilkens, P., Martens, W., Gervois, P., Ratajczak, J., Struys, T., & Lambrichts, I. (2014) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.02.013 · Cited by 359
Metadata
- Authors
- Suzuki, K., Sun, R., Origuchi, M., Kanehira, M., Takahata, T., Itoh, J., Umezawa, A., Kijima, H., Fukuda, S., & Saijo, Y.
- Affiliations
- Hirosaki University (JP)
- Tohoku University (JP)
- National Center For Child Health and Development (JP)
- Corresponding author
- Saijo, Yasuo
- Venue
- Molecular Medicine
- Published
- 2011-03-11
- Volume
- 17
- Issue
- 7-8
- Pages
- 579-587
- ISSN
- 1076-1551 (ISSN-L)
- 1528-3658
- PMC
- PMC3146617
- OpenAlex
- W2207758069
- Cited by
- 244
- References
- 38
- Citations by year
- 2026: 6 · 2025: 12 · 2024: 11 · 2023: 10 · 2022: 12 · 2021: 17 · 2020: 24 · 2019: 19 · 2018: 25 · 2017: 14 · 2016: 25 · 2015: 16 · 2014: 21 · 2013: 12 · 2012: 17
- FWCI
- 8.44
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- Locations
- Molecular Medicine (publishedVersion, cc-by)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Japan Society for the Promotion of Science (16022206, 20390229, 23790895, 22659160)
- RIKEN
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Keywords
- mesenchymal stem cells, tumor growth, tumor angiogenesis, angiogenesis, tumor cell proliferation, bone marrow-derived stromal cells, Lewis lung carcinoma, leukemia inhibitory factor, macrophage colony-stimulating factor, CXCL2, vascular endothelial growth factor, tumor vasculature
- MeSH terms
- Animals, Cells, Cultured, Female, Flow Cytometry, Mice, Transgenic, Neoplasm Transplantation, Neoplasms, Experimental, Neovascularization, Pathologic, Macrophage Colony-Stimulating Factor, Microscopy, Confocal, Coculture Techniques, Antigens, CD34, Vascular Endothelial Growth Factor A, Mesenchymal Stem Cell Transplantation, Cell Line, Tumor, Tumor Burden, Cell Proliferation, Green Fluorescent Proteins, Mice, Chemokine CXCL2, Mesenchymal Stem Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review